C07K 14/471
Myotonic dystrophy
Official title: {Myotonic dystrophy}
C07K14/471 (Myotonic dystrophy) appears on 7 US grants and 11 published applications in this corpus.
Search patents in C07K- Granted patents
- 7
- Published applications
- 11
- Assignees
- 18
- Inventors
- 32
- Latest grant
- 23 Dec 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1996 | 1 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 1 |
| 2004 | 0 | 0 |
| 2005 | 1 | 1 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 1 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 1 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 1 | 0 |
| 2014 | 0 | 1 |
| 2015 | 1 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 1 |
| 2020 | 1 | 1 |
| 2021 | 0 | 1 |
| 2022 | 0 | 1 |
| 2023 | 0 | 2 |
| 2024 | 0 | 0 |
| 2025 | 1 | 0 |
| 2026 | 0 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Treatment of myotonic dystrophy23 Dec 2025US 12,503,495 B2Association Institut De Myologie
- Synthetic MBNL proteins for treatment of repeat expansion disease15 Dec 2020US 10,865,229 B2University of Florida Research Foundation, Inc.
- Methods and compositions for treatment of myotonic dystrophy25 Aug 2015US 9,114,178 B2Valerion Therapeutics, LLC
- Methods and compositions for treatment of myotonic dystrophy17 Dec 2013US 8,609,615 B2Valerion Therapeutics, LLC
- Intron associated with myotonic dystrophy type 2 and methods of use28 Oct 2008US 7,442,782 B2Regents of the University of Minnesota
- Genetic constructs for gene editing5 Mar 2026US 2026/0061074 A1Sarepta Therapeutics, Inc.
- A novel muscle-specific promoter7 Sep 2023US 2023/0277686 A1Genethon
- New tau species2 Feb 2023US 2023/0032690 A1Centre Hospitalier Regional Universitaire De Lille
- Gene therapy vectors29 Dec 2022US 2022/0411821 A1University of Florida Research Foundation, Inc.
- Treatment of myotonic dystrophy28 Jan 2021US 2021/0024597 A1Association Institut De Myologie
Most cited
By later US patents
- Intron associated with myotonic dystrophy type 2 and methods of use28US 6,902,896 B2Regents of the University of Minnesota · 2005
- Intron associated with myotonic dystrophy type 2 and methods of use26US 7,442,782 B2Regents of the University of Minnesota · 2008
- Diagnosis of myotonic muscular dystrophy14US 5,552,282 ABaylor College of Medicine · 1996
- Methods and compositions for treatment of myotonic dystrophy8US 8,609,615 B2Valerion Therapeutics, LLC · 2013
- Methods and compositions for treatment of myotonic dystrophy4US 9,114,178 B2Valerion Therapeutics, LLC · 2015